---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-094640"
form_type: "8-K"
ticker: "SVRA"
cik: "0001160308"
company_name: "Savara Inc"
filed_at: "2024-04-12T23:59:59+00:00"
generated_at: "2026-06-03T23:16:15.142231+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Savara director Dr. Ricky Sun not to stand for reelection; Bain waives board designation right

## Summary
- Dr. Ricky Sun notified Board on April 10, 2024 of intention not to stand for reelection at 2024 Annual Meeting; will serve until then.
- Sun's decision not related to any dispute or disagreement with Savara on operations, policies, or practices.
- Bain Capital Life Sciences permanently waived its right under 2019 Purchase Agreement to designate a Board member.
- Designation right was triggered when Bain held at least 50% of purchased shares or 5% of outstanding shares.

## SEC filing metadata
- accession: 0001193125-24-094640
- form_type: 8-K
- ticker: SVRA
- cik: 0001160308
- company_name: Savara Inc
- filed_at: 2024-04-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 8.01, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1160308/000119312524094640/0001193125-24-094640-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1160308/000119312524094640/d804195d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-094640
- JSON: https://secwatch.observer/filing/0001193125-24-094640.json
- Plain text: https://secwatch.observer/filing/0001193125-24-094640.txt

## Key facts
- Executive change
  Dr. Ricky Sun departed as Director at Savara Inc.
  - Action: not to stand for reelection
  - Role: Director
  source text: On April 10, 2024, Dr. Ricky Sun notified the Board of Directors (the “Board”) of Savara Inc. (the “Company”) of his intention not to stand for reelection to the Board following the expiration of his current term at the 2024 Annual Meeting of Stockholders (the “Annual Meeting”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1160308/000119312524094640/0001193125-24-094640-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.